Massive study seeks to unlock secrets of heart surgery recovery

NCT ID NCT07524998

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will analyze data from 3,000 people with complex congenital heart disease who have had or will have heart surgery in China. Researchers aim to identify key risk factors affecting recovery and build a quality control system to improve surgical care. Participants' medical records and follow-up data will be collected and combined into a registry.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could lead to better surgical care and recovery for people with complex congenital heart disease in China.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply outside China or to all patient groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fuwai Hospital, Chinese Academy of Medical Science, PUMC

    RECRUITING

    Beijing, 100037, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••